Guggenheim Maintains Buy on BrightSpring Health, Raises Price Target to $84

Benzinga · 3d ago
Guggenheim analyst Jason Cassorla maintains BrightSpring Health (NASDAQ:BTSG) with a Buy and raises the price target from $81 to $84.